<DOC>
	<DOCNO>NCT02853552</DOCNO>
	<brief_summary>The overall study purpose evaluate safety , feasibility acceptability advance distribution misoprostol use 'first aid treatment ' administer woman family help treat excessive bleeding home birth .</brief_summary>
	<brief_title>Misoprostol First Aid Measure Address Excessive Postpartum Bleeding</brief_title>
	<detailed_description>This quasi-experimental , pre-post intervention study conduct period 12 month span two phase : Phase 1 ( baseline ) ( 6 month ) : Data delivery collect pregnant woman deliver phase . Data also collect treatment administer PPH case . Women counsel also receive educational material identify excessive bleeding importance seek care facility excessive bleeding occurs . Phase 2 ( misoprostol ) ( 6 month ) : During phase , study pilot first aid concept . Women provide single dose 800 mcg sublingual misoprostol ( 200 mcg x 4 tablet ) third trimester use event excessive postpartum bleeding , well educational material counsel provided Phase 1 . The misoprostol intend serve first aid treatment measure although seek additional care challenge setting , woman family advise plan ready seek immediate care health facility soon take misoprostol . During study phase , data collect maternal , clinical , neonatal outcome delivery occur study area . If woman receive care relate delivery , data collector document information .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Pregnant woman live sample district Unable provide inform consent</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>